FDA gives preliminary approval to new insomnia drug

03/1/2004 | NYTimes.com

The FDA's "approvable" letter to Sepracor for its Estorra drug allows the Massachusetts drug company to bypass additional clinical or pre-clinical trials for the drug's final approval. The company said it hopes to begin marketing the drug as early as the middle of the year.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC